Dublin, May 06, 2025 (GLOBE NEWSWIRE) -- The "Chemiluminescence Immunoassay Analyzers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for ...

Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The global Chemiluminescence Immunoassay (CLIA) analyzers market size was USD 5.42 Billion in 2022 and is expected to register rapid revenue CAGR of 6.0% ...

Rising prevalence of chronic as well as acute diseases and technological advancements in CLIA analyzers are key factors driving market revenue growth. VANCOUVER, BRITISH COLUMBIA, CANADA, July 1, 2024 ...

An ethyl alcohol (ETOH) assay from Carolina Liquid Chemistries Corp. (CLC) has been categorized as moderately complex under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for use on the ...

PRINCETON, N.J., Jan. 19 Abbott announced todaythat the U.S. Food and Drug Administration (FDA) has granted waived statusunder the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for ...

Pune, Maharashtra, India, September 26 2022 (Wiredrelease) Prudour Pvt. Ltd –:Global Chemiluminescence Immunoassay market is projected to expand positively at a CAGR of 6.5% and is expected to reach ...

East Windsor, New Jersey, October 2, 2007 — Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted waived status under the Clinical Laboratory Improvement Amendements of ...

LONDON--(BUSINESS WIRE)--The global chemiluminescence analyzer market size is expected to grow by USD 5.04 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period.

This Clinical Laboratory Improvement Amendments (CLIA) training will be valuable to CLIA regulated, non-waived laboratories that run automated analyzers or semi-quantitative kit tests. It will ...

CHATSWORTH, Calif., Jan. 5, 2011 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and ...